Showing posts with label Toxicology. Show all posts
Showing posts with label Toxicology. Show all posts

Monday, 9 May 2016

PubMed Update April 2016

23 for this month! Lots of interesting stuff, from large-scale epidemiology to randomized controlled trials.

Krieter P, Chiang N, Gyaw S, Skolnick P, Crystal R, Keegan F, Aker J, Beck M, Harris J.
J Clin Pharmacol. 2016 May 5. doi: 10.1002/jcph.759. [Epub ahead of print]
Comment: Details on the pharmacokinetics and usability studies for the new nasal device.

Madah-Amiri D, Clausen T.
Addiction. 2016 May 3. doi: 10.1111/add.13400. [Epub ahead of print] No abstract available.
Comment: Large-scale naloxone requires public health support.

Wilkerson RG, Kim HK, Windsor TA, Mareiniss DP.
Emerg Med Clin North Am. 2016 May;34(2):e1-e23. doi: 10.1016/j.emc.2015.11.002. Epub 2016 Feb 17. Review.
Comment: Focuses on risk factors for problematic opioid use and naloxone.


Kunøe N, Opheim A, Solli KK, Gaulen Z, Sharma-Haase K, Latif ZE, Tanum L.
BMC Pharmacol Toxicol. 2016 Apr 28;17(1):18. doi: 10.1186/s40360-016-0061-1.
Comment: Methods paper for above planned study.

Arelin V, Schmidt JJ, Kayser N, Kühn-Velten WN, Suhling H, Eden G, Kielstein JT.
Clin Nephrol. 2016 Apr 27. [Epub ahead of print]
Comment: Doesn’t really remove methadone, so not useful in an overdose but also not problematic for patients on methadone undergoing light-chain removal.

Madah-Amiri D, Clausen T, Lobmaier P.
Drug Alcohol Depend. 2016 Apr 14. pii: S0376-8716(16)30034-5. doi: 10.1016/j.drugalcdep.2016.04.007. [Epub ahead of print]
Comment: Title is self-explanatory.

Weiner SG, Raja AS, Bittner JC, Curtis KM, Weimersheimer P, Hasegawa K, Espinola JA, Camargo CA Jr.
Acad Emerg Med. 2016 Apr 21. doi: 10.1111/acem.12992. [Epub ahead of print]
Comment: Intriguing look at ED policies in New England. 18% had an opioid screening tool, 78% used the PDMP, 41% alerted the primary doctor when prescribing opioids, 70% gave substance use treatment referrals, and 12% offered take-home naloxone.

Pade P, Fehling P, Collins S, Martin L.
Subst Abus. 2016 Apr 19:0. [Epub ahead of print]
Comment: Naloxone in a residential treatment program. Hopefully the first bit of data with much more to come.

Takeda MY, Katzman JG, Dole E, Bennett MH, Alchbli A, Duhigg D, Yonas H.
Subst Abus. 2016 Apr 19:0. [Epub ahead of print]
Comment: New Mexico study of 164 chronic pain patients on opioids who were provided naloxone. There were no overdoses.

Friedman MS, Manini AF.
J Med Toxicol. 2016 Apr 15. [Epub ahead of print]
Comment: Fascinating abstract – I don’t have full access. They set up “naloxone criteria” of (1) respiratory rate <12, miotic pupils, or drug paraphernalia, and (2) altered mental status by AVPU or GCS and then looked to see if those criteria predicted a beneficial effect of naloxone. They did – with an OR of 7 and 83% sensitivity. Miotic pupils were the best predictor of a response to naloxone. Authors also found that naloxone was underutilized – in only 44.2% of cases where it may have been beneficial. This is a fascinating area, as we don’t yet understand the reasons why naloxone is or is not administered in emergency services.

Darke S, Duflou J.
Addiction. 2016 Apr 15. doi: 10.1111/add.13429. [Epub ahead of print]
Comment: 6-MAM, the best way to confirm heroin as a cause of overdose death, is only present if the death occurs in under 30 minutes. In this study, 6-MAM was present in 43% of heroin overdose cases, suggesting that most people took longer to expire.

Lewis DA, Park JN, Vail L, Sine M, Welsh C, Sherman SG.
Am J Public Health. 2016 Apr 14:e1-e4. [Epub ahead of print]
Comment: Distribution program increased self-efficacy.

Chronister KJ, Lintzeris N, Jackson A, Ivan M, Dietze P, Lenton S, Kearley J, van Beek I.
Drug Alcohol Rev. 2016 Apr 13. doi: 10.1111/dar.12400. [Epub ahead of print]
Comment: First data on an Australian naloxone program. 83 people given naloxone. Among the 42% completing follow-up, 30 overdoses were successfully reversed and participants still felt informed and able to use naloxone.

Hoback J.
State Legis. 2016 Apr;42(4):9-13. No abstract available.
Comment: On a quick glance, seems a bit inflammatory.

Harned M, Sloan P.
Expert Opin Drug Saf. 2016 Apr 26:1-8. [Epub ahead of print]
Comment: Prospective trials are needed to evaluate longterm opioid therapy for chronic pain.

Lee JD, Friedmann PD, Kinlock TW, Nunes EV, Boney TY, Hoskinson RA Jr, Wilson D, McDonald R, Rotrosen J, Gourevitch MN, Gordon M, Fishman M, Chen DT, Bonnie RJ, Cornish JW, Murphy SM, O'Brien CP.
N Engl J Med. 2016 Mar 31;374(13):1232-42. doi: 10.1056/NEJMoa1505409.
Comment: Pretty good data on extended-release naltrexone and low overdose risk. Unfortunately, overdose wasn’t specifically asked about, but instead was treated as any other adverse events in a clinical trial and had to be reported by the participants.

Yablonsky TA, Thompson GL.
W V Med J. 2016 Mar-Apr;112(2):16-7. No abstract available.
Comment: Can’t access, but there are a lot.

Hein H, Püschel K, Schaper A, Iwersen-Bergmann S.
Arch Kriminol. 2016 Jan-Feb;237(1-2):38-46. German.
Comment: Lockboxes.

Asplund J.
Hosp Health Netw. 2016 Jan;90(1):20, 22, 2.
Comment: This is apparently about police and naloxone.

Rudd RA, Aleshire N, Zibbell JE, Gladden RM.
MMWR Morb Mortal Wkly Rep. 2016 Jan 1;64(50-51):1378-82. doi: 10.15585/mmwr.mm6450a3.
Comment: Really well done. Discusses opioids in a sophisticated and honest manner. Impressive work from the CDC.

Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF.
Ann Intern Med. 2016 Jan 5;164(1):1-9. doi: 10.7326/M15-0038. Epub 2015 Dec 29.
Comment: Patients who have an overdose usually continue to receive opioids. If opioids stop, they have a lower risk of recurrent overdose.

Sgarlato A, deRoux SJ.
Forensic Sci Med Pathol. 2015 Sep;11(3):388-94. doi: 10.1007/s12024-015-9699-z. Epub 2015 Aug 2.
Comment: 36.7% of decedents had a valid opioid prescription; benzos were involved in 68.4% of cases with alprazolam the most common (35.1%).

Darke S, Slade T, Ross J, Marel C, Mills KL, Tessson M.
Addict Behav. 2015 Nov;50:78-83. doi: 10.1016/j.addbeh.2015.06.030. Epub 2015 Jun 14.
Comment: Heavy drinking was associated with overdose (OR 1.6).

Monday, 18 August 2014

PubMed Update July 2014

Hooray for a mere 7 paper reprieve this month.

Mertz KJ, Janssen JK, Williams KE.
J Forensic Sci. 2014 Jul 16. doi: 10.1111/1556-4029.12541. [Epub ahead of print]
Comments: This manuscript presents critical and very concerning results regarding interpretation of our prescription opioid overdose epidemic. Morphine and codeine are commonly present and without 6-MAM (a third heroin metabolite) present at sufficient levels those deaths are coded as morphine and codeine. On this review of 112 such deaths, 66% met criteria for heroin involvement based on a history of heroin use (which may not be sufficient given the frequent use of other opioids among heroin users), drug paraphernalia or stamp bags, track marks, and detection of 6-MAM (generally at very low levels). Good toxicologists always check for 6-MAM so that shouldn’t be a major issue, but it is conceivable that some of these morphine/codeine cases are in fact heroin – an important caveat as we respond to the epidemic.

Trafton JA, Oliva EM.
Addiction. 2014 Aug;109(8):1243-4. doi: 10.1111/add.12585. No abstract available.
Comments: Authors argue that Good Samaritan and naloxone legislation may be effective strategies to reduce overdose.

Yen YF, Yen MY, Lin T, Li LH, Jiang XR, Chou P, Deng CY.
BMC Public Health. 2014 Jul 4;14(1):682. doi: 10.1186/1471-2458-14-682.
Comments: Again, HIV infection is associated with a history of overdose among persons who inject drugs.

Taheri F, Yaraghi A, Sabzghabaee AM, Moudi M, Eizadi-Mood N, Gheshlaghi F, Farajzadegan Z.
J Res Pharm Pract. 2013 Jul;2(3):130-4. doi: 10.4103/2279-042X.122387.
Comments: an analysis of methadone poisonings in Iran. Among 385 patients, 57.7% of cases were “intentional” and demonstrated high rates of psychiatric disorders (25.8%). Among the full cohort, 40% had opioid use disorders and 25.5% were in a methadone program.


Dupuy G, Cavalcanti L, Bourgogne E, Brichant-Petitjean C, Gomberoff L, Bloch V, Bellivier F, Lépine JP, Laprévote O, Vorspan F.
Harm Reduct J. 2014 Jul 2;11(1):20. doi: 10.1186/1477-7517-11-20.
Comments: There is residual methadone in take-home containers. Proper disposal or a consideration of alternative deliveries is important to minimize the risk of accidental exposures.

Goodloe JM.
EMS World. 2014 May;43(5):51-2. No abstract available.
Comments: I’m unable to access this.

Alcorn T.
Lancet. 2014 Jun 7;383(9933):1957-8. No abstract available.

Comments: A summary of what’s going on in the United States regarding naloxone.

Tuesday, 8 July 2014

PubMed Update May/June 2014


25 papers in two months. Anyone want to help with this?

Sabzghabaee AM, Eizadi-Mood N, Yaraghi A, Zandifar S.
Arch Med Sci. 2014 May 12;10(2):309-14. doi: 10.5114/aoms.2014.42584. Epub 2014 May 13.
PMID: 24904666 [PubMed] Free PMC Article
Comments: More data to support the utility of intranasal naloxone for overdose reversal. There are, however, some odd findings that suggest caution in interpreting the paper. The authors used 0.4mg of naloxone for IV or IN administration, whereas most efforts utilize 2mg for IN administration given the lower bioavailability. Moreover, they had a higher level of consciousness in the IN group, which seems odd.

Rambod M, Elhanafi S, Mukherjee D.
Ann Noninvasive Electrocardiol. 2014 Jun 5. doi: 10.1111/anec.12171. [Epub ahead of print]
PMID: 24903622 [PubMed - as supplied by publisher]
Comments: There are cases in which opioids can result in unstable heart rhythms. Usually this is related to high dose methadone, prolongation of the QT interval and torsades de pointes. In this case, heroin plus alcohol may have resulted in electrical conduction similar to “Brugada syndrome” which, in the interest of having an image in this blog post, I’ve posted an image of here. This type of electrical conduction is usually genetic and can result in sudden death through lethal arrhythmias.


Clark AK, Wilder CM, Winstanley EL.
J Addict Med. 2014 May-Jun;8(3):153-63. doi: 10.1097/ADM.0000000000000034.
PMID: 24874759 [PubMed - in process]
Comments: An impressive review of existing data for naloxone programs. Big kudos to the authors.

Iwersen-Bergmann S, Jungen H, Andresen-Streichert H, Müller A, Elakkary S, Püschel K, Heinemann A.
Int J Legal Med. 2014 May 25. [Epub ahead of print]
PMID: 24859230 [PubMed - as supplied by publisher]
Comments: Interesting analysis of methadone-related deaths among methadone maintenance patients suggesting that, while overdose deaths are not common, many may have been related to IV use of methadone.

Liu X, Wang G, Pu H, Jing H.
Brain Res. 2014 Jul 14;1572:40-9. doi: 10.1016/j.brainres.2014.05.016. Epub 2014 May 20.
PMID: 24854119 [PubMed - in process]
Comments: Intriguing analysis of rat brains suggesting a key role of calcium in neurotoxicity related to heroin use. Do medications like verapamil, generally used to manage hypertension, have a role in preventing neurologic damage from opioids and perhaps even reducing overdose risk?

Wang KH, Fiellin DA, Becker WC.
Am J Drug Alcohol Abuse. 2014 Jul;40(4):292-303. doi: 10.3109/00952990.2014.907301. Epub 2014 May 22.
PMID: 24853143 [PubMed - in process]
Comments: Around a fifth of people using prescription opioids “non-medically” get them directly from a physician.


Koller AC, Salcido DD, Menegazzi JJ.
Prehosp Emerg Care. 2014 May 15. [Epub ahead of print]
PMID: 24831102 [PubMed - as supplied by publisher]
Comments: A survey mostly of physicians and paramedics showing that healthcare providers manage cardiac arrest differently if it is from drug overdose versus a different etiology. This sounds quite reasonable, actually, since etiology-specific management is encouraged particularly for cardiac arrests due to “pulseless electrical activity” (that is, while we shock most arrhythmias during cardiac arrest, if there is no arrhythmia to shock we generally don’t shock and do a bunch of other things – one of those things is to guess what may be causing the cardiac arrest and administering medications to try to counteract that problem).

Koller AC, Salcido DD, Callaway CW, Menegazzi JJ.
Resuscitation. 2014 Jun 26. pii: S0300-9572(14)00581-4. doi: 10.1016/j.resuscitation.2014.05.036. [Epub ahead of print]
PMID: 24973558 [PubMed - as supplied by publisher]
Comments: Overdose-related cardiac arrests are more likely to survive. They are also more likely to be younger and to receive different immediate care. These findings are consistent with the above opinion survey.

Green TC, Ray M, Bowman SE, McKenzie M, Rich JD.
Subst Abus. 2014;35(2):129-32. doi: 10.1080/08897077.2013.825691.
PMID: 24821348 [PubMed - in process]
Comments: There have been rare cases of naloxone self-administration in the setting of lay naloxone programs. This obviously should not be the goal, as most people in need of naloxone will be unconscious by the time they need it.

Farsi D, Mirafzal A, Hassanian-Moghaddam H, Azizi Z, Jamshidnejad N, Zehtabchi S.
Cardiovasc Toxicol. 2014 May 9. [Epub ahead of print]
PMID: 24811951 [PubMed - as supplied by publisher]
Comments: Prolonged QT interval in methadone overdose patients predicts respiratory arrest, need for intubation, and death.

Zlotorzynska M, Milloy MJ, Richardson L, Nguyen P, Montaner JS, Wood E, Kerr T.
Int J Drug Policy. 2014 Apr 4. pii: S0955-3959(14)00075-9. doi: 10.1016/j.drugpo.2014.03.014. [Epub ahead of print]
PMID: 24795288 [PubMed - as supplied by publisher]
Comments: People overdose when they get their monthly assistance checks. There are some programs that provide “money management” services, doling out participants monthly incomes over time – these may help to reduce binge drug use and related overdose events.

[No authors listed]
Med Lett Drugs Ther. 2014 Mar 17;56(1438):21-2. No abstract available.
PMID: 24662159 [PubMed - indexed for MEDLINE]
Comments: Unable to access.

Schuman-Olivier Z, Connery H, Griffin ML, Wyatt SA, Wartenberg AA, Borodovsky J, Renner JA Jr, Weiss RD.
Am J Addict. 2013 Nov-Dec;22(6):574-80. doi: 10.1111/j.1521-0391.2013.12024.x. Epub 2013 Apr 11.
PMID: 24131165 [PubMed - indexed for MEDLINE]
Comments: About 40% of providers think buprenorphine/naloxone diversion is a problem. I’m unable to access the article, but the abstract says providers who have experience using the medication think diversion is a result of limited access to the medication. I concur with that opinion … but I am also one of those providers.

Heilbronn C, Lloyd B, McElwee P, Eade A, Lubman DI.
Drug Alcohol Rev. 2013 Jul;32(4):405-11. doi: 10.1111/dar.12028. Epub 2013 Jan 27.
PMID: 23350582 [PubMed - indexed for MEDLINE]
Comments: Quetiapine is a sedating anti-psychotic that is often favored by those with opioid use disorders.

Stöver HJ, Schäffer D.
Harm Reduct J. 2014 Jun 27;11(1):18. [Epub ahead of print]
PMID: 24973031 [PubMed - as supplied by publisher] Free Article
Comments: Efforts to transition users from injection to smoking heroin in Europe seem to be growing in popularity with increasing evidence of effectiveness. Of note, one major limitation is the pH of different formulations of heroin. Heroin in the United States, for example, may be too acidic for most users to transition to smoking (which generally requires a “basic” acid/base balance to allow the drug to be vaporized without burning).

Unick G, Rosenblum D, Mars S, Ciccarone D.
Addiction. 2014 Jun 17. doi: 10.1111/add.12664. [Epub ahead of print]
PMID: 24938727 [PubMed - as supplied by publisher]
Comments: Purity of heroin has some association with overdose and there seems to be a difference in the geographic source of the heroin in terms of overdose risk.

Hammett TM, Phan S, Gaggin J, Case P, Zaller N, Lutnick A, Kral AH, Fedorova EV, Heimer R, Small W, Pollini R, Beletsky L, Latkin C, Des Jarlais DC.
BMC Health Serv Res. 2014 Jun 17;14:261. doi: 10.1186/1472-6963-14-261.
PMID: 24938376 [PubMed - in process] Free PMC Article
Comments: Notwithstanding many efforts to expand the role of pharmacists in community health, the legal and social stigma surrounding injection drug use seriously limits the implementation and impact of these policy and programmatic efforts. I can only imagine this is going to get worse before it gets better, as pharmacists are increasingly being held to higher standards of evaluating the appropriateness of prescriptions for patients.

Zedler B, Xie L, Wang L, Joyce A, Vick C, Kariburyo F, Rajan P, Baser O, Murrelle L.
Pain Med. 2014 Jun 14. doi: 10.1111/pme.12480. [Epub ahead of print]
PMID: 24931395 [PubMed - as supplied by publisher]
Comments: Dose, dependence, prior overdose, liver disease and use of long-acting opioids were the primary predictors of overdose.

Hadland SE, DeBeck K, Kerr T, Nguyen P, Simo A, Montaner JS, Wood E.
J Adolesc Health. 2014 Jun 9. pii: S1054-139X(14)00191-8. doi: 10.1016/j.jadohealth.2014.04.013. [Epub ahead of print]
PMID: 24925493 [PubMed - as supplied by publisher]
Comments: INSITE serves the population of extremely high-risk, young injectors.

Davis CS, Ruiz S, Glynn P, Picariello G, Walley AY.
Am J Public Health. 2014 Jun 12:e1-e3. [Epub ahead of print]
PMID: 24922133 [PubMed - as supplied by publisher]
Comments: This policy review is, I believe, the first publication in the scientific literature on the relatively new phenomenon of providing non-ACLS trained first responders with naloxone.

Bileviciute-Ljungar I, Häglund V, Carlsson J, von Heijne A.
J Rehabil Med. 2014 Jun 4. doi: 10.2340/16501977-1820. [Epub ahead of print]
PMID: 24909124 [PubMed - as supplied by publisher]
Comments: Methadone overdose has resulted in a delayed leukoencephalopathy – basically a sickness in the white matter of the brain. This can result in substantial and lifelong dysfunction. There is some improvement, but it can require a fair amount of medication and still have at least moderate neurologic dysfunction that may never resolve. If you know someone who had a methadone overdose and they don’t seem to be getting better, this should be considered.

Mettner J.
Minn Med. 2014 Apr;97(4):10-1. No abstract available.
PMID: 24868924 [PubMed - indexed for MEDLINE]
Comments: Can’t access.

Jacobson J.
Am J Nurs. 2014 May;114(5):22-3. doi: 10.1097/01.NAJ.0000446774.91899.b5. No abstract available.
PMID: 24759473 [PubMed - indexed for MEDLINE]
Comments: A news article on naloxone.

Gwira Baumblatt JA, Wiedeman C, Dunn JR, Schaffner W, Paulozzi LJ, Jones TF.
JAMA Intern Med. 2014 May;174(5):796-801.
PMID: 24589873 [PubMed - indexed for MEDLINE]
Comments: Opioid overdose deaths in Tennessee had, compared to national data, an abundance of what is referred to as “doctor shopping.” Among patients prescribed opioids, 7.6% had >4 prescribers and 2.5% >4 pharmacies. While one should be cautious about overinterpreting the number of prescribers (as perhaps they were urgent care or other affiliated providers filling in for the primary prescriber), most analyses suggest that around 1% of patients fit the pharmacy criteria. These patients were the most likely to die of opioid overdose.

Favrod-Coune T, Baroudi M, Casillas A, Rieder JP, Gétaz L, Barro J, Gaspoz JM, Broers B, Wolff H.
Swiss Med Wkly. 2013 Nov 1;143:w13898. doi: 10.4414/smw.2013.13898.
PMID: 24186493 [PubMed - indexed for MEDLINE] Free Article
Comments: In-prison methadone maintenance.

Nielsen MK, Johansen SS, Linnet K.
Drug Alcohol Depend. 2013 Dec 1;133(2):447-51. doi: 10.1016/j.drugalcdep.2013.07.001. Epub 2013 Jul 25.
PMID: 23891033 [PubMed - indexed for MEDLINE]
Comments: Investigators were unable to establish a methodology that would allow them to distinguish between those who had reduced tolerance and those who did not, among methadone overdose deaths.